Medical Device News Magazine

Colorado Springs Urological Associates (CSUA) Signed Definitive Agreement With Solaris Health to Join the Nation’s Largest Urological Services Provider

CSUA Seizes Innovation Opportunities Presented by Dynamic National Urology Platform Caring for More than One-Half Million Patients

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Solaris Health Holdings announced today that Colorado Springs Urological Associates (CSUA), serving Colorado Springs, CO, and the surrounding area, has entered into a definitive agreement to join as an affiliate practice. Terms have not been disclosed.

The agreement with CSUA extends the reach of the national Solaris platform to the Mountain West. Solaris is the nation’s leading provider of independent urological services. CSUA will become the fifth urology practice this year to join Solaris.

CSUA is a union of two patient-centric, top-rated urological practices, tracing its roots back 50 years. Upon closing, the addition of CSUA means that Solaris now aligns the skills and talents of 345 providers who care for over 530,000 unique patients each year at more than 135 sites in New York, Ohio, Pennsylvania, Kentucky, Indiana, Illinois, Michigan, and Colorado. The deal is expected to close in Q4 of 2021.

“We welcome CSUA as a practice that shares our vision to develop a national practice predicated on clinical excellence and business best practices,” stated Solaris Chairman and Chief Ecosystem Officer Deepak A. Kapoor, MD. Solaris President, Gary M. Kirsh, MD added, “By choosing to scale nationally, CSUA physicians will maintain their high standards of patient care and gain access to the resources needed to successfully navigate an increasingly complex and consolidated health care system.”

CSUA Market President Jeffrey Moody, MD announced, “The doctors and staff of Colorado Springs Urological Associates are excited about our new partnership with Solaris Health. This brings an entirely new dimension of care, access, service, and technology to southern Colorado urology. We are thrilled to continue to advance the care we provide our community.”

Jeffrey Ferguson, MD, CSUA Director of Business Development and Strategy, added, “This partnership will give our team access to a national urology platform with expertise in clinical care and practice management and help us improve the service we provide to our patients and our community.” Dr. Ferguson will serve on the Solaris Board of Directors.

“The addition of Colorado Springs Urological Associates demonstrates that the appeal of our platform is not constrained by geography and represents a significant boost to the momentum we are building for even greater expansion,” said Eric Mason, MD, MBA, Solaris Health CEO.

McDermott Will & Emery LLP served as legal counsel to Solaris. Physician Growth Partners acted as exclusive financial advisor to CSUA and Lathrop GPM LLP served as legal counsel to CSUA.

New York-based Lee Equity Partners is a financial partner in Solaris.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”